¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 1Zp/EYWa{  
(i(E~^O  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© tvVf)bbz  
ns5Dydo{T  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© gn/]1NNfR  
6W3oIt  
1.Co-stimulators (or co-stimulating molecules) $ e L-fg  
>{~xO 6H  
2.NK-kB i83Jy w,f  
Bx}"X?%S  
3.Immunoglobulin superfamily r8*xp\/  
|zfFB7}v  
4.antigen-presenting cell (APC) WhH60/`  
I+kL;YdS  
5.death domain tFn[U#'  
+& f_k@+  
6.CCR and CXCR ^9hc`.5N&?  
RaTNA W)v>  
7.Lectin (or mitogen) E>*b,^J7g  
@##}zku  
8.Clusters of differentiation, CD) CpX[8>&osD  
@%u}|iF|  
9.B7 family fM] nP4K`  
,*lns.|n  
10.Cytotoxic T lymphocyte, CTL) 5Y`4%*$  
g]44|9x(W  
11.IL-15 and IL-15 receptor (IL-15R) }2BNy9q@  
s/~[/2[bnf  
12.MHC restriction im:[ViR {  
V?^qW#AG  
13.Affinity-chromatography SV ~QH&0'  
oui0:Vy<  
14.Cyctosprin A, CsA 3 Z SU^v  
=w_T{V  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) a>8] +@  
;2fzA<RkK  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© u\xrC\Ka  
]+qd|}^  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 <daH0l0  
GP ^^ K  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ {t0!N]'  
wp~KrUlR  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ y\iECdPU  
`+TC@2-?  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 6,~ %  
g;o5m }  
ÃâÒßѧרҵ£º :N<o<qn  
8h}1t4k  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ _Eq,udCso  
~ U8#yo  
Ïû»¯ÄÚ¿Æ£º Vn/FW?d7  
>K%+h)%kI  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ Lq@uwiq!  
T`I4_x  
ѪҺ²¡Ñ§×¨Òµ£º &;vMJ   
J<cY'?D  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»